Tropicamide/phenylephrine
From WikiProjectMed
Jump to navigation
Jump to search
Medication
Combination of | |
---|---|
Tropicamide | Anticholinergic |
Phenylephrine | Alpha-1 adrenergic receptor agonist |
Clinical data | |
Trade names | Mydcombi |
Routes of administration | Topical, ophthalmic |
ATC code | |
Legal status | |
Legal status |
Tropicamide/phenylephrine, sold under the brand name Mydcombi is a fixed dose combination of tropicamide and phenylephrine used to dilate the eyes (mydriasis).[1] It contains, tropicamide, an anticholinergic, and phenylephrine, as the hydrochloride, an alpha-1 adrenergic receptor agonist.[1] It is sprayed into the eyes.[1]
It was approved for medical use in the United States in May 2023.[2][3]
Medical uses
Tropicamide/phenylephrine is used for the short-term dilation of the pupils.[1]
References
- ^ a b c d e https://mydcombi.com/wp-content/uploads/2023/05/MydCombi-PI-05072023.pdf
- ^ "Mydcombi: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 8 May 2023.
- ^ "Eyenovia Announces FDA Approval of Mydcombi, the First Ophthalmic Spray for Mydriasis, Which Also Leverages the Company's Proprietary Optejet Device Platform". Eyenovia. 8 May 2023. Retrieved 8 May 2023.
External links
- Clinical trial number NCT03751631 for "Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation (MIST-1)" at ClinicalTrials.gov
- Clinical trial number NCT03751098 for "Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation (MIST-2)" at ClinicalTrials.gov
α1 |
| ||||
---|---|---|---|---|---|
α2 |
| ||||
β |
| ||||
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://mdwiki.org/wiki/Tropicamide/phenylephrine"
Categories:
- Articles with short description
- Short description with empty Wikidata description
- Use American English from May 2023
- All Wikipedia articles written in American English
- Use dmy dates from May 2023
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Alpha-1 adrenergic receptor agonists
- Combination drugs
- Muscarinic antagonists
- Ophthalmic drug administration
- All stub articles
- Pharmacology stubs